1
|
Friedenstein AJ, Chailakhjan RK and
Lalykina KS: The development of fibroblast colonies in monolayer
cultures of guinea-pig bone marrow and spleen cells. Cell Tissue
Kinet. 3:393–403. 1970.PubMed/NCBI View Article : Google Scholar
|
2
|
Williams JT, Southerland SS, Souza J,
Calcutt AF and Cartledge RG: Cells isolated from adult human
skeletal muscle capable of differentiating into multiple mesodermal
phenotypes. Am Surg. 65:22–26. 1999.PubMed/NCBI
|
3
|
Toma JG, Akhavan M, Fernandes KJ,
Barnabé-Heider F, Sadikot A, Kaplan DR and Miller FD: Isolation of
multipotent adult stem cells from the dermis of mammalian skin. Nat
Cell Biol. 3:778–784. 2001.PubMed/NCBI View Article : Google Scholar
|
4
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: Implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001.PubMed/NCBI View Article : Google Scholar
|
5
|
Erices A, Conget P and Minguell JJ:
Mesenchymal progenitor cells in human umbilical cord blood. Br J
Haematol. 109:235–242. 2000.PubMed/NCBI View Article : Google Scholar
|
6
|
Gronthos S, Mankani M, Brahim J, Robey PG
and Shi S: Postnatal human dental pulp stem cells (DPSCs) in vitro
and in vivo. Proc Natl Acad Sci USA. 97:13625–13630.
2000.PubMed/NCBI View Article : Google Scholar
|
7
|
Seo BM, Miura M, Gronthos S, Bartold PM,
Batouli S, Brahim J, Young M, Robey PG, Wang CY and Shi S:
Investigation of multipotent postnatal stem cells from human
periodontal ligament. Lancet. 364:149–155. 2004.PubMed/NCBI View Article : Google Scholar
|
8
|
Miura M, Gronthos S, Zhao M, Lu B, Fisher
LW, Robey PG and Shi S: SHED: Stem cells from human exfoliated
deciduous teeth. Proc Natl Acad Sci USA. 100:5807–5812.
2003.PubMed/NCBI View Article : Google Scholar
|
9
|
Ferraro F, Celso CL and Scadden D: Adult
stem cels and their niches. Adv Exp Med Biol. 695:155–168.
2010.PubMed/NCBI View Article : Google Scholar
|
10
|
Cheung AS, Zhang DK, Koshy ST and Mooney
DJ: Scaffolds that mimic antigen-presenting cells enable ex vivo
expansion of primary T cells. Nat Biotechnol. 36:160–169.
2018.PubMed/NCBI View
Article : Google Scholar
|
11
|
Padma AM, Carrière L, Krokström Karlsson
F, Sehic E, Bandstein S, Tiemann TT, Oltean M, Song MJ, Brännström
M and Hellström M: Towards a bioengineered uterus: Bioactive sheep
uterus scaffolds are effectively recellularized by enzymatic
preconditioning. NPJ Regen Med. 6(26)2021.PubMed/NCBI View Article : Google Scholar
|
12
|
Martin I, Galipeau J, Kessler C, Le Blanc
K and Dazzi F: Challenges for mesenchymal stromal cell therapies.
Sci Transl Med. 11(11)2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Galipeau J and Sensébé L: Mesenchymal
stromal cells: Clinical challenges and therapeutic opportunities.
Cell Stem Cell. 22:824–833. 2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Guillonneau X, Tassin J, Berrou E,
Bryckaert M, Courtois Y and Mascarelli F: In vitro changes in
plasma membrane heparan sulfate proteoglycans and in perlecan
expression participate in the regulation of fibroblast growth
factor 2 mitogenic activity. J Cell Physiol. 166:170–187.
1996.PubMed/NCBI View Article : Google Scholar
|
15
|
Brewer JR, Mazot P and Soriano P: Genetic
insights into the mechanisms of Fgf signaling. Genes Dev.
30:751–771. 2016.PubMed/NCBI View Article : Google Scholar
|
16
|
Ortega S, Ittmann M, Tsang SH, Ehrlich M
and Basilico C: Neuronal defects and delayed wound healing in mice
lacking fibroblast growth factor 2. Proc Natl Acad Sci USA.
95:5672–5677. 1998.PubMed/NCBI View Article : Google Scholar
|
17
|
Montero A, Okada Y, Tomita M, Ito M,
Tsurukami H, Nakamura T, Doetschman T, Coffin JD and Hurley MM:
Disruption of the fibroblast growth factor-2 gene results in
decreased bone mass and bone formation. J Clin Invest.
105:1085–1093. 2000.PubMed/NCBI View
Article : Google Scholar
|
18
|
Lou ZC and Wang YB: Healing outcomes of
large (>50%) traumatic membrane perforations with inverted edges
following no intervention, edge approximation and fibroblast growth
factor application; a sequential allocation, three-armed trial.
Clin Otolaryngol. 38:289–296. 2013.PubMed/NCBI View Article : Google Scholar
|
19
|
Mattoli S, Stacey MA, Sun G, Bellini A and
Marini M: Eotaxin expression and eosinophilic inflammation in
asthma. Biochem Biophys Res Commun. 236:299–301. 1997.PubMed/NCBI View Article : Google Scholar
|
20
|
Kitaura M, Nakajima T, Imai T, Harada S,
Combadiere C, Tiffany HL, Murphy PM and Yoshie O: Molecular cloning
of human eotaxin, an eosinophil-selective CC chemokine, and
identification of a specific eosinophil eotaxin receptor, CC
chemokine receptor 3. J Biol Chem. 271:7725–7730. 1996.PubMed/NCBI View Article : Google Scholar
|
21
|
Ogilvie P, Bardi G, Clark-Lewis I,
Baggiolini M and Uguccioni M: Eotaxin is a natural antagonist for
CCR2 and an agonist for CCR5. Blood. 97:1920–1924. 2001.PubMed/NCBI View Article : Google Scholar
|
22
|
Villeda SA, Luo J, Mosher KI, Zou B,
Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, et al:
The ageing systemic milieu negatively regulates neurogenesis and
cognitive function. Nature. 477:90–94. 2011.PubMed/NCBI View Article : Google Scholar
|
23
|
Czepielewski LS, Massuda R, Panizzutti B,
Grun LK, Barbé-Tuana FM, Teixeira AL, Barch DM and Gama CS:
Telomere length and CCL11 levels are associated with gray matter
volume and episodic memory performance in schizophrenia: Evidence
of pathological accelerated aging. Schizophr Bull. 44:158–167.
2018.PubMed/NCBI View Article : Google Scholar
|
24
|
Huber AK, Giles DA, Segal BM and Irani DN:
An emerging role for eotaxins in neurodegenerative disease. Clin
Immunol. 189:29–33. 2018.PubMed/NCBI View Article : Google Scholar
|
25
|
Wang W, Huang CY, Wang ZP, Xu SS, Qian TY,
Chen YD and Wu WG: Serum C-C motif ligand 11/eotaxin-1 may serve as
a candidate biomarker for postmenopausal osteoporosis. J Med
Biochem. 38:353–360. 2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Kindstedt E, Holm CK, Sulniute R,
Martinez-Carrasco I, Lundmark R and Lundberg P: CCL11, a novel
mediator of inflammatory bone resorption. Sci Rep.
7(5334)2017.PubMed/NCBI View Article : Google Scholar
|
27
|
Akazawa Y, Hasegawa T, Yoshimura Y, Chosa
N, Asakawa T, Ueda K, Sugimoto A, Kitamura T, Nakagawa H, Ishisaki
A, et al: Recruitment of mesenchymal stem cells by stromal
cell-derived factor 1α in pulp cells from deciduous teeth. Int J
Mol Med. 36:442–448. 2015.PubMed/NCBI View Article : Google Scholar
|
28
|
Iwamoto T, Nakamura T, Ishikawa M,
Yoshizaki K, Sugimoto A, Ida-Yonemochi H, Ohshima H, Saito M,
Yamada Y and Fukumoto S: Pannexin 3 regulates proliferation and
differentiation of odontoblasts via its hemichannel activities.
PLoS One. 12(e0177557)2017.PubMed/NCBI View Article : Google Scholar
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
30
|
Kikuchi N, Kitamura C, Morotomi T, Inuyama
Y, Ishimatsu H, Tabata Y, Nishihara T and Terashita M: Formation of
dentin-like particles in dentin defects above exposed pulp by
controlled release of fibroblast growth factor 2 from gelatin
hydrogels. J Endod. 33:1198–1202. 2007.PubMed/NCBI View Article : Google Scholar
|
31
|
Kim YS, Min KS, Jeong DH, Jang JH, Kim HW
and Kim EC: Effects of fibroblast growth factor-2 on the expression
and regulation of chemokines in human dental pulp cells. J Endod.
36:1824–1830. 2010.PubMed/NCBI View Article : Google Scholar
|
32
|
Sagomonyants K, Kalajzic I, Maye P and
Mina M: FGF signaling prevents the terminal differentiation of
odontoblasts. J Dent Res. 96:663–670. 2017.PubMed/NCBI View Article : Google Scholar
|
33
|
Sagomonyants K, Kalajzic I, Maye P and
Mina M: Enhanced dentinogenesis of pulp progenitors by early
exposure to FGF2. J Dent Res. 94:1582–1590. 2015.PubMed/NCBI View Article : Google Scholar
|
34
|
Coffin JD, Florkiewicz RZ, Neumann J,
Mort-Hopkins T, Dorn GW II, Lightfoot P, German R, Howles PN, Kier
A and O'Toole BA: Abnormal bone growth and selective translational
regulation in basic fibroblast growth factor (FGF-2) transgenic
mice. Mol Biol Cell. 6:1861–1873. 1995.PubMed/NCBI View Article : Google Scholar
|
35
|
Tang MM, Lin WJ, Zhang JT, Zhao YW and Li
YC: Exogenous FGF2 reverses depressive-like behaviors and restores
the suppressed FGF2-ERK1/2 signaling and the impaired hippocampal
neurogenesis induced by neuroinflammation. Brain Behav Immun.
66:322–331. 2017.PubMed/NCBI View Article : Google Scholar
|
36
|
Pan X, Xu S, Zhou Z, Wang F, Mao L, Li H,
Wu C, Wang J, Huang Y, Li D, et al: Fibroblast growth factor-2
alleviates the capillary leakage and inflammation in sepsis. Mol
Med. 26(108)2020.PubMed/NCBI View Article : Google Scholar
|
37
|
Garmy-Susini B, Delmas E, Gourdy P, Zhou
M, Bossard C, Bugler B, Bayard F, Krust A, Prats AC, Doetschman T,
et al: Role of fibroblast growth factor-2 isoforms in the effect of
estradiol on endothelial cell migration and proliferation. Circ
Res. 94:1301–1309. 2004.PubMed/NCBI View Article : Google Scholar
|
38
|
Presta M, Andrés G, Leali D, Dell'Era P
and Ronca R: Inflammatory cells and chemokines sustain FGF2-induced
angiogenesis. Eur Cytokine Netw. 20:39–50. 2009.PubMed/NCBI View Article : Google Scholar
|
39
|
Gronthos S, Brahim J, Li W, Fisher LW,
Cherman N, Boyde A, DenBesten P, Robey PG and Shi S: Stem cell
properties of human dental pulp stem cells. J Dent Res. 81:531–535.
2002.PubMed/NCBI View Article : Google Scholar
|
40
|
Vaseenon S, Chattipakorn N and
Chattipakorn SC: The possible role of basic fibroblast growth
factor in dental pulp. Arch Oral Biol. 109(104574)2020.PubMed/NCBI View Article : Google Scholar
|
41
|
Büttner R, Schulz A, Reuter M, Akula AK,
Mindos T, Carlstedt A, Riecken LB, Baader SL, Bauer R and Morrison
H: Inflammaging impairs peripheral nerve maintenance and
regeneration. Aging Cell. 17(e12833)2018.PubMed/NCBI View Article : Google Scholar
|
42
|
Gauvreau GM, Boulet LP, Cockcroft DW,
Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K,
Duong M, et al: Antisense therapy against CCR3 and the common beta
chain attenuates allergen-induced eosinophilic responses. Am J
Respir Crit Care Med. 177:952–958. 2008.PubMed/NCBI View Article : Google Scholar
|
43
|
Pease JE and Williams TJ: Tipping the
balance: A biased nanobody antagonist of CCR3 with potential for
the treatment of eosinophilic inflammation. J Allergy Clin Immunol.
143:552–553. 2019.PubMed/NCBI View Article : Google Scholar
|
44
|
Hayashi Y, Kawamura R, Nishimatsu SI,
Fukuta O and Nakashima M: Stem cell-induced pulp regeneration can
be enhanced by administration of CCL11-neutralizing antibody in the
ectopic tooth transplantation model in the aged mice. Rejuvenation
Res. 22:51–59. 2019.PubMed/NCBI View Article : Google Scholar
|
45
|
Mills CD, Kincaid K, Alt JM, Heilman MJ
and Hill AM: M-1/M-2 macrophages and the Th1/Th2 paradigm. J
Immunol. 164:6166–6173. 2000.PubMed/NCBI View Article : Google Scholar
|
46
|
Abd-Elmeguid A, Abdeldayem M, Kline LW,
Moqbel R, Vliagoftis H and Yu DC: Osteocalcin expression in pulp
inflammation. J Endod. 39:865–872. 2013.PubMed/NCBI View Article : Google Scholar
|
47
|
Bikfalvi A, Klein S, Pintucci G and Rifkin
DB: Biological roles of fibroblast growth factor-2. Endocr Rev.
18:26–45. 1997.PubMed/NCBI View Article : Google Scholar
|
48
|
Powers CJ, McLeskey SW and Wellstein A:
Fibroblast growth factors, their receptors and signaling. Endocr
Relat Cancer. 7:165–197. 2000.PubMed/NCBI View Article : Google Scholar
|
49
|
Kunath T, Saba-El-Leil MK, Almousailleakh
M, Wray J, Meloche S and Smith A: FGF stimulation of the Erk1/2
signalling cascade triggers transition of pluripotent embryonic
stem cells from self-renewal to lineage commitment. Development.
134:2895–2902. 2007.PubMed/NCBI View Article : Google Scholar
|
50
|
Haghighi F, Dahlmann J, Nakhaei-Rad S,
Lang A, Kutschka I, Zenker M, Kensah G, Piekorz RP and Ahmadian MR:
bFGF-mediated pluripotency maintenance in human induced pluripotent
stem cells is associated with NRAS-MAPK signaling. Cell Commun
Signal. 16(96)2018.PubMed/NCBI View Article : Google Scholar
|
51
|
Ma Y, Kakudo N, Morimoto N, Lai F,
Taketani S and Kusumoto K: Fibroblast growth factor-2 stimulates
proliferation of human adipose-derived stem cells via Src
activation. Stem Cell Res Ther. 10(350)2019.PubMed/NCBI View Article : Google Scholar
|
52
|
Franceschi RT and Ge C: Control of the
Osteoblast Lineage by Mitogen-Activated Protein Kinase Signaling.
Curr Mol Biol Rep. 3:122–132. 2017.PubMed/NCBI View Article : Google Scholar
|